HK142395A - Phenylquinolinecarboxylic acids and derivatives as antitumor agents - Google Patents

Phenylquinolinecarboxylic acids and derivatives as antitumor agents

Info

Publication number
HK142395A
HK142395A HK142395A HK142395A HK142395A HK 142395 A HK142395 A HK 142395A HK 142395 A HK142395 A HK 142395A HK 142395 A HK142395 A HK 142395A HK 142395 A HK142395 A HK 142395A
Authority
HK
Hong Kong
Prior art keywords
carbon atoms
alkyl
compound
solvent
independently
Prior art date
Application number
HK142395A
Other languages
German (de)
English (en)
French (fr)
Inventor
Paul Hesson David
Original Assignee
The Du Pont Merck Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Du Pont Merck Pharmaceutical Company filed Critical The Du Pont Merck Pharmaceutical Company
Publication of HK142395A publication Critical patent/HK142395A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK142395A 1983-07-22 1995-09-07 Phenylquinolinecarboxylic acids and derivatives as antitumor agents HK142395A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631983A 1983-07-22 1983-07-22
US60510484A 1984-04-30 1984-04-30

Publications (1)

Publication Number Publication Date
HK142395A true HK142395A (en) 1995-09-15

Family

ID=27058797

Family Applications (1)

Application Number Title Priority Date Filing Date
HK142395A HK142395A (en) 1983-07-22 1995-09-07 Phenylquinolinecarboxylic acids and derivatives as antitumor agents

Country Status (16)

Country Link
EP (1) EP0133244B1 (forum.php)
AU (1) AU583793B2 (forum.php)
CA (1) CA1288436C (forum.php)
DE (1) DE3483704D1 (forum.php)
DK (1) DK358784A (forum.php)
ES (1) ES534509A0 (forum.php)
FI (1) FI86987C (forum.php)
GR (1) GR82234B (forum.php)
HK (1) HK142395A (forum.php)
HU (1) HU194832B (forum.php)
IE (1) IE57627B1 (forum.php)
IL (1) IL72471A (forum.php)
NO (1) NO167510C (forum.php)
NZ (1) NZ208966A (forum.php)
PT (1) PT78960B (forum.php)
SU (2) SU1393314A3 (forum.php)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
HUT55742A (en) * 1987-12-28 1991-06-28 Dowelanco Process for producing (phenoxy-phenoxy)-propionate derivatives and theyr new intermediates
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US4968702A (en) * 1989-01-17 1990-11-06 American Cyanamid Company Substituted quinolinecarboxylic acids
US4918077A (en) * 1989-01-25 1990-04-17 E. I. Du Pont De Nemours & Co., Inc. 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
DE3905339A1 (de) * 1989-02-22 1990-09-06 Basf Ag Chinolin-4-carbonsaeurederivate und deren verwendung
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
TW416948B (en) * 1993-12-28 2001-01-01 Merck & Co Inc Process for the preparation of leukotriene antagonists
PL194980B1 (pl) * 1997-05-28 2007-07-31 Aventis Pharma Inc Nowe związki chinolinowe i chinoksalinowe, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
AU2201699A (en) * 1997-12-19 1999-07-12 Eli Lilly And Company Hypoglycemic imidazoline compounds
AU2003244080A1 (en) * 2002-06-26 2004-01-19 Kyowa Hakko Kogyo Co., Ltd. Phosphodiesterase inhibitor
TW200804288A (en) * 2005-12-12 2008-01-16 Astrazeneca Ab Alkylsulphonamide quinolines
US8232310B2 (en) * 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
MX377618B (es) 2012-04-12 2025-03-07 Univ Georgetown Métodos y composiciones para el tratamiento de la familia de tumores del sarcoma de ewing.
EP3060207A4 (en) 2013-10-24 2017-04-12 Georgetown University Methods and compositions for treating cancer
EP3071199A2 (en) 2013-11-22 2016-09-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases
NZ730585A (en) 2014-10-09 2018-08-31 Oncternal Therapeutics Inc Indolinone compounds and uses thereof
DK3436434T3 (da) 2016-03-31 2020-09-21 Oncternal Therapeutics Inc Indolin-analoger og anvendelser deraf
EP3490553B1 (en) 2016-07-29 2024-08-28 Oncternal Therapeutics, Inc. Combination comprising an indolinone compound and its use in the treatment of lymphoma
EP4081215A4 (en) * 2019-12-26 2024-01-10 Ohio State Innovation Foundation METHODS AND COMPOSITIONS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE502610A (forum.php) * 1950-04-18
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds

Also Published As

Publication number Publication date
FI86987C (fi) 1992-11-10
NO842969L (no) 1985-01-23
AU583793B2 (en) 1989-05-11
IE841873L (en) 1985-01-22
EP0133244A3 (en) 1985-12-11
FI86987B (fi) 1992-07-31
IL72471A (en) 1988-11-15
NO167510B (no) 1991-08-05
HU194832B (en) 1988-03-28
AU3085284A (en) 1985-01-24
FI842928A0 (fi) 1984-07-20
EP0133244B1 (en) 1990-12-05
SU1393314A3 (ru) 1988-04-30
ES8507498A1 (es) 1985-09-01
PT78960A (en) 1984-08-01
EP0133244A2 (en) 1985-02-20
NZ208966A (en) 1986-12-05
GR82234B (forum.php) 1984-12-13
PT78960B (en) 1986-10-20
SU1452480A3 (ru) 1989-01-15
FI842928L (fi) 1985-01-23
HUT35248A (en) 1985-06-28
NO167510C (no) 1991-11-13
DK358784D0 (da) 1984-07-20
DK358784A (da) 1985-01-23
CA1288436C (en) 1991-09-03
ES534509A0 (es) 1985-09-01
DE3483704D1 (de) 1991-01-17
IE57627B1 (en) 1993-02-10
IL72471A0 (en) 1984-11-30

Similar Documents

Publication Publication Date Title
US4680299A (en) 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
EP0133244B1 (en) Phenylquinolinecarboxylic acids and derivatives as antitumor agents
CA1087205A (en) 2-amino-3-(5-and 6-)benzoylphenylacetic acids, esters and metal salts thereof
JPS6089474A (ja) モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤
US4374990A (en) Cyclic diamine derivatives
US4639454A (en) Phenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agents
JPS62103065A (ja) ピリジン誘導体
SK27598A3 (en) Piperazine derivatives and process for the preparation thereof
US4053607A (en) Aryloxypyridine for treating hyperglycaemia
EP2208725A1 (en) Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
Aytemir et al. Anticonvulsant and neurotoxicity evaluation of some novel kojic acids and allomaltol derivatives
EP1142885B1 (en) 2-(n-cyanoimino)thiazolidin-4-one derivatives
EP0145010B1 (en) Carbostyril derivatives
EP0228959B1 (en) Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same
SU1223843A3 (ru) Способ получени 1-фенил-2-аминокарбонилиндольных соединений или их кислотно-аддитивных солей
JPH03141258A (ja) 新規なピペラジン誘導体
US7863323B1 (en) Flavonols
AU623481B2 (en) 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
US5032597A (en) Method of using phenylquinolinecarboxylic acids and derivatives for lymthoid leukemia treatment in a mammal
KR950001040B1 (ko) 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제
US4297357A (en) N-Phenethylacetamide compounds and process for preparation thereof
JPH0519549B2 (forum.php)
JPH01250316A (ja) 抗脂血剤
EP0282077A2 (en) Pyridyloxy derivatives
RU2126001C1 (ru) Производные пиперазина и фармацевтическая композиция на их основе

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)